Leriglitazone
Chemical compound / From Wikipedia, the free encyclopedia
Leriglitazone is a PPAR-gamma agonist and metabolite of the glitazone pioglitazone. It is developed for adrenomyeloneuropathy, and other neurodegenerative diseases.[1][2][3][4]
Quick Facts Clinical data, Other names ...
Clinical data | |
---|---|
Other names | Hydroxypioglitazone |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C19H20N2O4S |
Molar mass | 372.44 g·mol−1 |
3D model (JSmol) | |
| |
|
Close